@article{81981b343b884b15acd6caba6d179699,
title = "Introduction to {\textquoteleft}Proceedings from Amyloidosis, A Hidden Disease with a Bright Future: A Multi-Disciplinary Approach to Diagnosis and Management of Amyloidosis{\textquoteright}",
author = "Zhang, {Kathleen W.} and Lenihan, {Daniel J.}",
note = "Funding Information: Conflicts of Interest: KWZ reports consulting fees from Eidos Therapeutics and BridgeBio Pharma. DJL reports research support from Alnylam, Eidos, Prothena Corporation, Pfizer Inc, and Jazz Pharmaceuticals; and consulting fees from Bristol-Myers Squibb, Ipsen Biopharmaceuticals, Prothena, Acorda Therapeutics, Lilly (Eli) USA, and Roche Pharmaceutical. Funding Information: This article is published as part of a supplement supported by unrestricted educational grants from Alnylam Pharmaceuticals and Janssen Pharmaceuticals. ",
year = "2022",
month = apr,
doi = "10.1016/j.amjmed.2022.01.010",
language = "English (US)",
volume = "135",
pages = "S1",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
}